These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20887762)

  • 21. Pediatric microdose and microtracer studies using 14C in Europe.
    Turner MA; Mooij MG; Vaes WH; Windhorst AD; Hendrikse NH; Knibbe CA; Kõrgvee LT; Maruszak W; Grynkiewicz G; Garner RC; Tibboel D; Park BK; de Wildt SN
    Clin Pharmacol Ther; 2015 Sep; 98(3):234-7. PubMed ID: 26095095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety.
    Wotherspoon AT; Safavi-Naeini M; Banati RB
    Bioanalysis; 2017 Dec; 9(23):1913-1933. PubMed ID: 29171759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanding utility of microdosing.
    Lappin G
    Clin Pharmacol Drug Dev; 2015 Nov; 4(6):401-6. PubMed ID: 27137711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of accelerator mass spectrometry to obtain early human ADME/PK data.
    Lappin G; Garner RC
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):23-31. PubMed ID: 16922650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-linearity of the pharmacokinetics of an intravenous [
    van Groen BD; Vaes WH; Park BK; Krekels EHJ; van Duijn E; Kõrgvee LT; Maruszak W; Grynkiewicz G; Garner RC; Knibbe CAJ; Tibboel D; de Wildt SN; Turner MA
    Br J Clin Pharmacol; 2019 Oct; 85(10):2332-2340. PubMed ID: 31269280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of liquid chromatography tandem mass spectrometry as an analytical method in microdose clinical studies.
    Yamane N; Tozuka Z; Kusama M; Maeda K; Ikeda T; Sugiyama Y
    Pharm Res; 2011 Aug; 28(8):1963-72. PubMed ID: 21472491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range.
    Sandhu P; Vogel JS; Rose MJ; Ubick EA; Brunner JE; Wallace MA; Adelsberger JK; Baker MP; Henderson PT; Pearson PG; Baillie TA
    Drug Metab Dispos; 2004 Nov; 32(11):1254-9. PubMed ID: 15286054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of human phase 0 microdosing trials: A systematic review and perspectives.
    Svendsen P; El-Galaly TC; Dybkær K; Bøgsted M; Laursen MB; Schmitz A; Jensen P; Johnsen HE
    Leuk Lymphoma; 2016; 57(6):1281-90. PubMed ID: 26428262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.
    Garner CR; Park KB; French NS; Earnshaw C; Schipani A; Selby AM; Byrne L; Siner S; Crawley FP; Vaes WH; van Duijn E; deLigt R; Varendi H; Lass J; Grynkiewicz G; Maruszak W; Turner MA
    Br J Clin Pharmacol; 2015 Jul; 80(1):157-67. PubMed ID: 25619398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.
    Burt T; Vuong LT; Baker E; Young GC; McCartt AD; Bergstrom M; Sugiyama Y; Combes R
    Altern Lab Anim; 2018 Dec; 46(6):335-346. PubMed ID: 30657329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening.
    Xiao H; Sun M; Zhao R; Hong H; Zhang A; Zhang S; Liu F; Zhang Y; Liu Y; Zhu L; Kung HF; Qiao J
    J Pharm Biomed Anal; 2018 May; 154():48-56. PubMed ID: 29533858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microdosing: the new pharmacokinetic paradigm?
    Zanni GR; Wick JY
    Consult Pharm; 2006 Oct; 21(10):756-76. PubMed ID: 17243857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Image-driven pharmacokinetics: nanomedicine concentration across space and time.
    Brill DA; MacKay JA
    Nanomedicine (Lond); 2015; 10(18):2861-79. PubMed ID: 26370694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microdosing of protein drugs.
    Rowland M
    Clin Pharmacol Ther; 2016 Feb; 99(2):150-2. PubMed ID: 26452582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
    Bauer M; Langer O; Dal-Bianco P; Karch R; Brunner M; Abrahim A; Lanzenberger R; Hofmann A; Joukhadar C; Carminati P; Ghirardi O; Piovesan P; Forloni G; Corrado ME; Lods N; Dudczak R; Auff E; Kletter K; Müller M
    Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing.
    Combes RD; Berridge T; Connelly J; Eve MD; Garner RC; Toon S; Wilcox P
    Eur J Pharm Sci; 2003 May; 19(1):1-11. PubMed ID: 12729856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular imaging with SPECT as a tool for drug development.
    Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
    Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of microdosing and accelerator mass spectrometry to evaluate the pharmacokinetic linearity of a novel tricyclic GyrB/ParE inhibitor in rats.
    Malfatti MA; Lao V; Ramos CL; Ong VS; Turteltaub KW
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6477-83. PubMed ID: 25136019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.
    Ings RM
    Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.